glp 1 precursor GLP-1 Body-wide multi-omic counteraction of aging
Description
One large 2024 study in the journal Scientific Reports found that people with obesity who were taking GLP-1s had a slightly elevated risk of anxiety and suicidal behavior when compared to a control group, and almost double the risk of major depression
Obesity is a chronic disease
Compounded medications are not FDA-approved finished drug products
Canal de Velasco LM, Gonzlez Flores JE, Azcona Cervera A, Morales Arteaga JL, Olivares Casas MJ
They manage it
